Combined use of toll-like receptor agonists and prostaglandin E2 in the FastDC model: Rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production

Journal of Immunological Methods

Volumn 337, Issue 2, 2008, Pages 97-105

  Dauer, Marc ^a   Lam, Veronique ^a   Arnold, Hannah ^a   Junkmann, Jana ^a   Kiefl, Rosemarie ^a   Bauer, Christian ^a   Schnurr, Max ^a   Endres, Stefan ^a   Eigler, Andreas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Dendritic cells; IL 12p70; Maturation; Migration; Prostaglandin E2; Toll like receptor

Indexed keywords

CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ARTICLE; CANCER IMMUNIZATION; CELL CULTURE; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; DINOPROSTONE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; MONOCYTES; NEOPLASM PROTEINS; RECEPTORS, CCR7; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTORS;

EID: 49449093282     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.07.003     Document Type: Article

References (34)

1. Assier E., Marin-Esteban V., Haziot A., Maggi E., Charron D., and Mooney N. TLR7/8 agonists impair monocyte-derived dendritic cell differentiation and maturation. J. Leukoc. Biol. 81 1 (2007) 221
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767
3. Bekeredijan-Ding I., Roth S.I., Gilles S., Giese T., Ablasser A., Hornung V., Endres S., and Hartmann G. T cell-independent, TLR-induced IL-12p70 production in primary human monocytes. J. Immunol. 176 12 (2006) 7438
4. Caux C., Dezutter-Dambuyant C., Schmitt D., and Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360 6401 (1992) 258
5. Cerundolo V., Hermans I.F., and Salio M. Dendritic cells: a journey from laboratory to clinic. Nat. Immunol. 5 1 (2004) 7
6. Czerniecki B.J., Carter C., Rivoltini L., Koski G.K., Kim H.I., Weng D.E., Roros J.G., Hijazi Y.M., Xu S., Rosenberg S.A., and Cohen P.A. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J. Immunol. 159 8 (1997) 3823
7. Dauer M., Obermaier B., Herten J., Haerle C., Pohl K., Rothenfusser S., Schnurr M., Endres S., and Eigler A. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J. Immunol. 170 8 (2003) 4069
8. Dauer M., Herten J., Bauer C., Renner F., Schad K., Schnurr M., Endres S., and Eigler A. Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells. J. Immunother. 28 4 (2005) 332
9. Dauer M., Schad K., Herten J., Junkmann J., Bauer C., Kiefl R., Endres S., and Eigler A. FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells. J. Immunol. Methods 302 1-2 (2005) 145
10. Dauer M., Schad K., Junkmann J., Bauer C., Herten J., Kiefl R., Schnurr M., Endres S., and Eigler A. IFN-alpha promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4. J. Leukoc. Biol. 80 2 (2006) 278
11. Eberhard J., Jepsen S., Pohl L., Albers H.K., and Acil Y. Bacterial challenge stimulates formation of arachidonic acid metabolites by human keratinocytes and neutrophils in vitro. Clin. Diagn. Lab. Immunol. 9 (2002) 132
12. Feuerstein B., Berger T.G., Maczek C., Roder C., Schreiner D., Hirsch U., Haendle I., Leisgang W., Glaser A., Kuss O., Diepgen T.L., Schuler G., and Schuler-Thurner B. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J. Immunol. Methods 245 1-2 (2000) 15
13. Fong L., and Engleman E.G. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18 (2000) 245
14. Fong L., Hou Y., Rivas A., Benike C., Yuen A., Fisher G.A., Davis M.M., and Engleman E.G. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. U. S. A. 98 15 (2001) 8809
15. Gilboa E. DC-based cancer vaccines. J. Clin. Invest. 117 5 (2007) 1195
16. Ginhoux F., Tacke F., Angeli V., Bogunovic M., Loubeau M., Dai X.M., Stanley E.R., Randolph G.J., and Merad M. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7 3 (2006) 265
17. Kabashima K., Sakata D., Nagamachi M., Miyachi Y., Inaba K., and Narumiya S. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9 6 (2003) 744
18. Kalinski P., Vieira P.L., Schuitemaker J.H., de Jong E.C., and Kapsenberg M.L. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97 11 (2001) 3466
19. Lehner M., Morhart P., Stilper A., and Holter W. Functional characterization of monocyte-derived dendritic cells generated under serumfree culture conditions. Immunol. Lett. 99 2 (2005) 209
20. Luft T., Jefford M., Luetjens P., Toy T., Hochrein H., Masterman K.A., Maliszewski C., Shortman K., Cebon J., and Maraskovsky E. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100 4 (2002) 1362
21. Luft T., Rodionova E., Maraskovsky E., Kirsch M., Hess M., Buchholtz C., Goerner M., Schnurr M., Skoda R., and Ho A.D. Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signals. Blood 107 12 (2006) 4763
22. Mailliard R.B., Wankowicz-Kalinska A., Cai Q., Wesa A., Hilkens C.M., Kapsenberg M.L., Kirkwood J.M., Storkus W.J., and Kalinski P. alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res. 64 17 (2004) 5934
23. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., and Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6 8 (2005) 769
24. Obermaier B., Dauer M., Herten J., Schad K., Endres S., and Eigler A. Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes. Biol. Proced. Online 5 (2003) 197
25. Palucka A.K., and Banchereau J. Langerhans cells: daughters of monocytes. Nat. Immunol. 7 3 (2006) 223
26. Peng J.C., Thomas R., and Nielsen L.K. Generation and maturation of dendritic cells for clinical application under serum-free conditions. J. Immunother. 28 6 (2005) 599
27. Peng J.C., Hyde C., Pai S., O'Sullivan B.J., Nielsen L.K., and Thomas R. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions. J. Immunother. 29 6 (2006) 606
28. Randolph G.J., Beaulieu S., Lebecque S., Steinman R.M., and Muller W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282 5388 (1998) 480
29. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.A., and Schuler G. Proliferating dendritic cells progenitors in human blood. J. Exp. Med. 180 1 (1994) 83
30. Santini S.M., Lapenta C., Logozzi M., Parlato S., Spada M., Di Pucchio T., and Belardelli F. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191 10 (2000) 1777
31. Schuler G., Schuler-Thurner B., and Steinman R.M. The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15 2 (2003) 138
32. Tacke F., Ginhoux F., Jakubzick C., van Rooijen N., Merad M., and Randolph G.J. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J. Exp. Med. 203 3 (2006) 583
33. Weck M.M., Grunebach F., Werth D., Sinzger C., Bringmann A., and Brossart P. TLR ligands differentially affect uptake and presentation of cellular antigens. Blood 109 9 (2007) 3890
34. Zobywalski A., Javorovic M., Frankenberger B., Pohla H., Kremmer E., Bigalke I., and Schendel D.J. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70. J. Transl. Med. 5 (2007) 18